Have you ever heard about an amazing guy named Dr. Clay Siegall? Do you have any interest in cancer research? Well, have you ever dealt with cancer on a first-hand basis? Despite the previous questions, Dr. Clay Siegall is very important to cancer research. He is one of the most celebrated individuals in this exclusive field. His educational background is legendary thanks to having a B.S. in Zoology as well as having a Ph.D in Genetics. These two degrees came from the University of Maryland and from George Washington University. Siegall has been the winner of numerous industry-related awards such as the Pacific Northwest Ernst & Young Entrepreneur of the Year as well as the University of Maryland Alumnus of the Year for Computer, Math & Science.
“Hard work has made me successful,” said Siegall. This man consistently quotes the affluent Charles Darwin on a regular basis. “Man doesn’t significantly differ on intellect, and IQ is secondary,” said Siegall. Rigorous Research, drug development and scientific innovation are three of his firm principles. These principles are what his company is built upon. This company just so happens to be Seattle Genetics, and it has set the precedent in cancer research. Since it specializes in developing and commercializing cancer fighting medications, it generates enormous amounts of wealth on an annual basis. The company’s top drug, ADCETRIS, has earned well-over $350 million, and the medication has only been on the market since 2011. ADCETRIS is being distributed on a worldwide scale of up to 70 countries. That’s right! These advanced medications are benefiting people thousands of miles away and that’s a great thing.
Though this company is already experiencing great success, it will definitely continue to push for more developments in the future. The future seems to be in good hands and Dr. Clay Siegall is one of the main solutions for such success.